Ihr Weg zu geschäftlicher Agilität
Dr. Sonnenblick, Chief Data Scientist bei Planview, verfügt über langjährige Erfahrung in der Zusammenarbeit mit einigen der größten Pharma- und Biowissenschaftsunternehmen der Welt. Dank des im Rahmen seiner Arbeit gewonnenen Wissens hat er erfolgreich aufschlussreiche Priorisierungs- und Portfoliobewertungsprozesse, Scoring-Systeme sowie finanzielle Bewertungs- und Prognosemethoden zur Verbesserung von Produktprognosen und Portfolioanalysen entwickelt. Dr. Sonnenblick hat einen Ph.D. und einen Master in Engineering and Public Policy von der Carnegie Mellon University sowie einen Bachelor in Physik von der University of California Santa Cruz.
It’s a familiar refrain from the project and portfolio managers we talk to: “These portfolio views are amazing, but there is no way we have the data to use Enrich Analytics.” We LOVE hearing this, because we can respond with good news: You probably have enough information to leverage our tools and gain big insights...
It’s time to network and share best-practices! The next six months is high season for conferences, and Enrich is excited to sponsor eight different events across North America and Europe between now and March 2017. While we recommend all of these conferences as excellent opportunities to network, learn from your peers, and share your...
We’re often asked, “What’s the best metric for portfolio management?” Executives and managers who oversee new product portfolios want one metric that will tell them, and their superiors, how their portfolios and the initiatives within them are doing. They want one indicator they can rely upon, whether in formal portfolio reviews or informal discussions. But there is...
Our latest video covers prioritization by value metrics, when to use productivity metrics, how to build a frontier chart, and when to temper simple prioritization with more sophisticated methods. You can see it here, right now. As always, we’d love to hear your comments and suggestions on topics for future videos.
In most R&D organizations, the portfolio management team walks a narrow line between the project teams and the executives. The portfolio staff polls the project teams for information about each new and ongoing initiative, builds portfolio views, and shares the updated state of the portfolio with executives. In an ideal world, the portfolio team members...
Knowing the current cost and estimated value of every initiative in your portfolio is nice, but when executives meet for a review, what they really want to know is: What’s changed since the last review, was it good or bad, and why? The above is true whether a month, a quarter, or a year has...
You’re probably familiar with Gantt charts, which show project tasks, their duration, and their completion dates. For a specific project, project managers and executives use Gantt charts to quickly review upcoming activities. When reviewing a portfolio of projects, project managers sometimes continue to use Gantt charts, adding upcoming tasks for all projects to a single...
“Hey Percy, what happened to the two medical writers who were supposed to start work with us this week?” “Oh, you didn’t hear, Luke? They were pulled to work on project PDE_311 at the last minute.” “Ugh, just like the bio-statistician that we were supposed to have last month!” said an exasperated Luke. “That’s the...
Uh-oh The goal of portfolio management is to effect changes that minimize risk and maximize value. But change is hard, and corporate change is harder still. People need motivation. The best way to build that motivation is to lay the consequences of the present course bare and make the status quo completely unpalatable. Like Thelma...
Watching Back To The Future again recently, I was horrified to realize that, at the end of the movie, the professor and Marty use their time machine to travel from 1985 to…wait for it…2015. They traveled 30 years into the future, and I’ve aged 30 years since last seeing the movie. Robert Zemeckis’s vision for The Future doesn’t...
